Risks
4 risks
Risk Intelligence
Raw Material Volatility
View Risks →Platinum Industries Ltd — Q4 FY26
Platinum Industries delivered a robust Q4 FY26 with consolidated revenue of ₹132 crore (+37% YoY), EBITDA of ₹15.3 crore (+95% YoY), and PAT of ₹14.8 crore (+164% YoY).
bullish
high
✓ Verified against BSE filing
2-Minute Summary
✦ AI-Generated from Full Transcript
Platinum Industries delivered a robust Q4 FY26 with consolidated revenue of ₹132 crore (+37% YoY), EBITDA of ₹15.3 crore (+95% YoY), and PAT of ₹14.8 crore (+164% YoY). EBITDA margin expanded 350 bps to 11.6%. Growth was driven by strong volume uptake in CPVC additives, improved product mix, and operational leverage from the new Palar facility. The CPVC segment contributed ~30% of FY26 revenue (₹110 crore) and is scaling rapidly with two major pipe manufacturers onboarded. Management guided for >40% revenue growth in FY27, supported by the Egypt plant (Q3 start, 10% of FY27 revenue) and a 35% CAGR target over FY26-29. Risks include raw material volatility (PVC/chemicals) and the time lag in passing on cost increases, which could temporarily pressure margins.
Risks4 trackedTranscriptfull text
Research workspace
Focused Modules
Transcript
Full text
Call Transcript
Full transcript text is available on this route.
Read Transcript →Quarter Snapshot
CPVC Revenue FY26
₹110 Cr
+100% YoY (approx)
CPVC contributed ~30% of total revenue; key growth driver.
Egypt Plant Capacity
60,000 TPA
New
Similar capacity as new Indian unit; commercial ops in Q3 FY27.
Oleochemicals Revenue Target FY27
₹55-60 Cr
New
First sale in April 2026; targeting meaningful contribution this year.
CPVC Additives Market Share Opportunity
50,000-1,00,000 tons
Expanding
India's CPVC pipe production expected to double to 5 lakh tons in 2-3 years.
What Changed vs Last Quarter
NEW
Egypt Plant Commercial Ops in Q3 FY27
Egypt facility to start commercial production in Q3 FY27, contributing ~10% of FY27 revenue.
NEW
EBITDA Margin Maintained at 13-15%
Management expects to maintain EBITDA margin in 13-15% range in FY27.
UPDATED
FY27 Revenue Growth >40%
Management targets >40% revenue growth in FY27, with 10% from Egypt and rest from India.
UPDATED
35% CAGR from FY26 to FY29
Long-term revenue CAGR target of 35% over FY26-29, supported by Egypt ramp-up and new products.
DROPPED
Egypt commercial production by September 2026
Egypt plant construction to complete by end of May 2026, pre-commissioning in June, commercial production by September 2026.
NEW RISK
Raw Material Volatility
Geopolitical tensions caused PVC and chemical price spikes in March; time lag in passing on costs may pressure margins.
NEW RISK
Egypt Plant Ramp-Up Risk
New Egypt facility may face operational or regulatory delays; break-even at 30-35% utilization.
NEW RISK
Employee Cost Increase
Employee costs rose due to hiring for new facilities; as % of sales increased by 1% and may not normalize quickly.
RISK GONE
Egypt plant execution delay
Egypt plant already delayed by 9-12 months; further delays could push revenue contribution beyond FY27.
RISK GONE
Promoter stake sale
Promoter sold ~0.87% stake in Q3 for personal loans, raising concerns about future dilution.
RISK GONE
Lead-based product regulatory risk
Global shift away from lead stabilizers could impact Egypt's lead-focused capacity, though management claims machines can be converted.
Fast read
Guidance and risk preview
Management targets >40% revenue growth in FY27, with 10% from Egypt and rest from India.
Geopolitical tensions caused PVC and chemical price spikes in March; time lag in passing on costs may pressure margins.
View Risks →